Evaluation of the efficacy and tolerance of artemether emulsion for the treatment of papulopustular rosacea: a randomized pilot study

Objective: To assess the efficacy and safety of artemether emulsion in patients with papulopustular rosacea. Methods: A total of 130 (randomized 1:1) were externally administered either artemether emulsion (1%) or metronidazole emulsion (3%) twice daily for 4 weeks with an open-label 8-week follow-u...

Full description

Bibliographic Details
Main Authors: Guo-Jiang Wang, Xiao-Yan Gao, Yun Wu, Hui-Qiong He, Yue Yu, Hai-Hong Qin, Wen-Tong Shen
Format: Article
Language:English
Published: Taylor & Francis Group 2019-11-01
Series:Journal of Dermatological Treatment
Subjects:
Online Access:http://dx.doi.org/10.1080/09546634.2019.1610549
_version_ 1797683668370587648
author Guo-Jiang Wang
Xiao-Yan Gao
Yun Wu
Hui-Qiong He
Yue Yu
Hai-Hong Qin
Wen-Tong Shen
author_facet Guo-Jiang Wang
Xiao-Yan Gao
Yun Wu
Hui-Qiong He
Yue Yu
Hai-Hong Qin
Wen-Tong Shen
author_sort Guo-Jiang Wang
collection DOAJ
description Objective: To assess the efficacy and safety of artemether emulsion in patients with papulopustular rosacea. Methods: A total of 130 (randomized 1:1) were externally administered either artemether emulsion (1%) or metronidazole emulsion (3%) twice daily for 4 weeks with an open-label 8-week follow-up. The primary endpoints included the proportion of patients who achieved clinical effective responses, as well as erythema and papule and pustule score at week 4. Results: Numerically more patients achieved an effective response at week 4 with artemether emulsion (87.1%) than metronidazole emulsion (80.0%) (p > .05). Patients with artemether emulsion had comparable baseline erythema score (2.45 ± 0.67 versus 2.42 ± 0.70, p = .809) and papule and pustule score (2.11 ± 0.96 versus 2.32 ± 0.83, p = .264), but significantly lower papule and pustule score (0.21 ± 0.52 versus 0.42 ± 0.83, p = .001) and comparable erythema score (0.53 ± 0.88 versus 0.62 ± 0.88, p = .999) compared to patients with metronidazole emulsion at week 4. There was a significantly higher proportion of patients with metronidazole emulsion relapse compared to metronidazole emulsion during the open-label 8-week follow-up period (21.6% versus 2.4%, p < .01). Conclusions: Artemether emulsion improved papulopustular rosacea in the metronidazole emulsion group as early as 4 weeks, but its beneficial effect was maintained through the 8-week follow-up period compared to metronidazole emulsion.
first_indexed 2024-03-12T00:18:21Z
format Article
id doaj.art-a3f441f05ad642cfbee22020f3176a49
institution Directory Open Access Journal
issn 0954-6634
1471-1753
language English
last_indexed 2024-03-12T00:18:21Z
publishDate 2019-11-01
publisher Taylor & Francis Group
record_format Article
series Journal of Dermatological Treatment
spelling doaj.art-a3f441f05ad642cfbee22020f3176a492023-09-15T14:23:02ZengTaylor & Francis GroupJournal of Dermatological Treatment0954-66341471-17532019-11-0130880981210.1080/09546634.2019.16105491610549Evaluation of the efficacy and tolerance of artemether emulsion for the treatment of papulopustular rosacea: a randomized pilot studyGuo-Jiang Wang0Xiao-Yan Gao1Yun Wu2Hui-Qiong He3Yue Yu4Hai-Hong Qin5Wen-Tong Shen6Shanghai University of Medicine&Health Sciences, Pudong New AreaPudong New AreaShanghai University of Medicine&Health Sciences, Pudong New AreaShanghai University of Medicine&Health Sciences, Pudong New AreaShanghai University of Medicine&Health Sciences, Pudong New AreaShanghai University of Medicine&Health Sciences, Pudong New AreaShanghai University of Medicine&Health Sciences, Pudong New AreaObjective: To assess the efficacy and safety of artemether emulsion in patients with papulopustular rosacea. Methods: A total of 130 (randomized 1:1) were externally administered either artemether emulsion (1%) or metronidazole emulsion (3%) twice daily for 4 weeks with an open-label 8-week follow-up. The primary endpoints included the proportion of patients who achieved clinical effective responses, as well as erythema and papule and pustule score at week 4. Results: Numerically more patients achieved an effective response at week 4 with artemether emulsion (87.1%) than metronidazole emulsion (80.0%) (p > .05). Patients with artemether emulsion had comparable baseline erythema score (2.45 ± 0.67 versus 2.42 ± 0.70, p = .809) and papule and pustule score (2.11 ± 0.96 versus 2.32 ± 0.83, p = .264), but significantly lower papule and pustule score (0.21 ± 0.52 versus 0.42 ± 0.83, p = .001) and comparable erythema score (0.53 ± 0.88 versus 0.62 ± 0.88, p = .999) compared to patients with metronidazole emulsion at week 4. There was a significantly higher proportion of patients with metronidazole emulsion relapse compared to metronidazole emulsion during the open-label 8-week follow-up period (21.6% versus 2.4%, p < .01). Conclusions: Artemether emulsion improved papulopustular rosacea in the metronidazole emulsion group as early as 4 weeks, but its beneficial effect was maintained through the 8-week follow-up period compared to metronidazole emulsion.http://dx.doi.org/10.1080/09546634.2019.1610549artemether emulsionrosaceaefficacysafetyrelapse
spellingShingle Guo-Jiang Wang
Xiao-Yan Gao
Yun Wu
Hui-Qiong He
Yue Yu
Hai-Hong Qin
Wen-Tong Shen
Evaluation of the efficacy and tolerance of artemether emulsion for the treatment of papulopustular rosacea: a randomized pilot study
Journal of Dermatological Treatment
artemether emulsion
rosacea
efficacy
safety
relapse
title Evaluation of the efficacy and tolerance of artemether emulsion for the treatment of papulopustular rosacea: a randomized pilot study
title_full Evaluation of the efficacy and tolerance of artemether emulsion for the treatment of papulopustular rosacea: a randomized pilot study
title_fullStr Evaluation of the efficacy and tolerance of artemether emulsion for the treatment of papulopustular rosacea: a randomized pilot study
title_full_unstemmed Evaluation of the efficacy and tolerance of artemether emulsion for the treatment of papulopustular rosacea: a randomized pilot study
title_short Evaluation of the efficacy and tolerance of artemether emulsion for the treatment of papulopustular rosacea: a randomized pilot study
title_sort evaluation of the efficacy and tolerance of artemether emulsion for the treatment of papulopustular rosacea a randomized pilot study
topic artemether emulsion
rosacea
efficacy
safety
relapse
url http://dx.doi.org/10.1080/09546634.2019.1610549
work_keys_str_mv AT guojiangwang evaluationoftheefficacyandtoleranceofartemetheremulsionforthetreatmentofpapulopustularrosaceaarandomizedpilotstudy
AT xiaoyangao evaluationoftheefficacyandtoleranceofartemetheremulsionforthetreatmentofpapulopustularrosaceaarandomizedpilotstudy
AT yunwu evaluationoftheefficacyandtoleranceofartemetheremulsionforthetreatmentofpapulopustularrosaceaarandomizedpilotstudy
AT huiqionghe evaluationoftheefficacyandtoleranceofartemetheremulsionforthetreatmentofpapulopustularrosaceaarandomizedpilotstudy
AT yueyu evaluationoftheefficacyandtoleranceofartemetheremulsionforthetreatmentofpapulopustularrosaceaarandomizedpilotstudy
AT haihongqin evaluationoftheefficacyandtoleranceofartemetheremulsionforthetreatmentofpapulopustularrosaceaarandomizedpilotstudy
AT wentongshen evaluationoftheefficacyandtoleranceofartemetheremulsionforthetreatmentofpapulopustularrosaceaarandomizedpilotstudy